AliveCor

By Aditi Pai November 17, 2015
Proteus Digital Health, which offers an ingestible sensor and digital medicine system, has hired Molly O’Neill as its chief commercial officer. O'Neill previously served as SVP of business development at Tenet Health, a healthcare services company. Before working at Tenet, O'Neill worked at Ascension Health Care Network, Inova Health System, and Duke University Health System. At Proteus, O'Neill...
By Brian Dolan November 11, 2015
San Francisco-based AliveCor, which offers smartphone-enabled ECG devices, has announced former Google SVP Vic Gundotra as its new CEO. Gundotra, who left Google in 2014 after eight years -- including a few heading up Google+, replaces Euan Thomson, an AliveCor board member and Khosla Ventures investor, who assumed the role of interim CEO in 2013. Gundotra becomes AliveCor's fourth CEO in almost...
By Aditi Pai October 29, 2015
The next generation of digital health offerings will use machine learning to treat patients more effectively, but it's still a decade away, according to Vinod Khosla, founder of Khosla Ventures, who spoke at Partners HealthCare's Connected Health Symposium in Boston this week. Khosla said no one can deny medicine has improved over the past 50 years, but it could be much better. One area ripe for...
By Jonah Comstock September 10, 2015
It's been almost a year since AliveCor began offering its first FDA-cleared algorithm, its atrial fibrillation detection algorithm, to customers. Now the company has released some data on how customers are using the algorithm to detect atrial fibrillation. According to AliveCor, 30 percent of AliveCor users have received a diagnosis of atrial fibrillation through the algorithm. More than half of...
By Jonah Comstock July 16, 2015
Utah health system Intermountain Healthcare -- and other, as yet unknown providers -- appear to be investigating AliveCor's smartphone ECG device in a clinical context, to determine whether the iPhone version of the device is comparable with traditional 12-lead ECGs. The trial aims to test the device with 50 patients who have possible ST Elevation Myocardial Infarction (STEMI), a common type of...
By Jonah Comstock June 22, 2015
A recent column in the Harvard Business Review says that two kinds of business strategies will dominate in the gold rush-like healthcare economy of the future: Goldminers and Bartenders. "The Goldminer strategy will typically involve vertically integrated players (large institutions like insurers, hospitals, and physicians’ groups) creating medical value by better managing the health of the...
By Aditi Pai March 12, 2015
Berkeley, California-based smartphone-enabled stethoscope company Eko Devices has raised $2 million in a round led by existing investor Founder.org with participation from Stanford StartX, and angels, including former HHS advisor John Noonan and the cofounders of music identification company Shazam. This brings the company's total funding to date to $2.8 million. Eko's device, called Core, hooks...
By Jonah Comstock February 23, 2015
AliveCor recalled Version 2.1.2 of its AliveECG iOS app under an FDA Class III recall according to an FDA posting that went up this month. But in actuality, the "recall," which happened in mid-January, was little more than a run-of-the-mill buggy app update, which the company patched within two days. "If you read the definitions of recall, if you, as a manufacturer of medical devices, place a...
By Aditi Pai February 10, 2015
The University of Southern California (USC) has launched a new app that takes some cues from Instagram, called Biogram, that allows users to take pictures, but that adds a stamp to the picture noting the user's heart rate. The pictures can be pushed to Facebook and other social media services. Biogram integrates heart rate data from AliveCor's smartphone ECG. If the user does not have an AliveCor...
By Jonah Comstock January 29, 2015
AliveCor's AF detection algorithm San Francisco-based AliveCor has received FDA clearance for two new algorithms for its smartphone-connected ECG: one that detects normality and one that detects interference. These follow up on AliveCor's atrial fibrillation detection algorithm that received clearance last fall. The Normal Detector assures patients that their ECG is free of abnormalities. If...

Editor's Pick